Home/Filings/4/0000950170-24-139240
4//SEC Filing

JOHNSON JOHN 4

Accession 0000950170-24-139240

CIK 0001697532other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:30 PM ET

Size

7.7 KB

Accession

0000950170-24-139240

Insider Transaction Report

Form 4
Period: 2024-12-19
Johnson John H
DirectorExecutive Chairman
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-19+1,000,0001,000,000 total
    Exercise: $1.02Exp: 2034-12-19Common Stock (1,000,000 underlying)
  • Award

    Common Stock

    2024-12-19+500,000500,000 total
Footnotes (2)
  • [F1]Consists of compensatory Restricted Stock Units ("RSUs") granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.
  • [F2]Consists of compensatory Options granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). The shares subject to the Option will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.

Documents

1 file

Issuer

Applied Therapeutics, Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001410781

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:30 PM ET
Size
7.7 KB